Cardinal Health (CAH) FY2020 results: revenue $152.9 billion, up 5.1% on the year
Cardinal Health Inc. (CAH) reported revenue of $152.9 billion for fiscal 2020, the year ended 30 June 2020, up 5.1% on the year before. Net income was -$3.7 billion, and diluted earnings per share $-12.61. The figures are the company's own, from the 10-K it filed with the SEC on 13 August 2020.
Revenue
$152.9 billion
+5.1% on the year
FY2013FY2020
Operating margin
-2.7%
1.4% a year earlier
FY2013FY2020
Net income
-$3.7 billion
FY2013FY2020
Diluted EPS
-$12.61
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
152,922
145,534
136,809
+5.1%
Cost of revenue
146,054
138,700
129,628
+5.3%
Gross profit
6,868
6,834
7,181
+0.5%
Gross margin
4.5%
4.7%
5.2%
Selling, general and administrative
4,572
4,480
4,596
+2.1%
Operating income
-4,098
2,060
126
Operating margin
-2.7%
1.4%
0.1%
Interest expense
238
294
329
-19.0%
Pre-tax income
-3,772
1,751
-228
Income tax
-79.0
386
-487
Effective tax rate
n/a
22.0%
n/a
Net income
-3,696
1,363
256
Net margin
-2.4%
0.9%
0.2%
Diluted EPS
-$12.61
$4.53
$0.81
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
1,960
2,722
2,768
-28.0%
Capital expenditure
375
328
384
+14.3%
Free cash flow
1,585
2,394
2,384
-33.8%
Free cash flow margin
1.0%
1.6%
1.7%
Cash from investing
493
338
-5,608
+45.9%
Cash from financing
-2,200
-2,293
-2,276
Depreciation and amortisation
913
1,000
1,032
-8.7%
Share-based compensation
90.0
82.0
85.0
+9.8%
Buybacks
350
600
550
-41.7%
Dividends paid
569
577
581
-1.4%
Dividend per share
$1.92
$1.91
$1.85
+0.5%
Diluted shares, weighted
293m
301m
315m
-2.7%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
1,789
6,328
6,059
-71.7%
Non-controlling interest
3.0
2.0
0.0
+50.0%
Redeemable equity
n/a
0.0
12.0
Debt
6,800
8,031
9,013
-15.3%
Operating lease liabilities
341
n/a
n/a
Finance lease liabilities
25.0
n/a
n/a
Other liabilities
31,808
26,602
24,867
+19.6%
Total liabilities and equity
40,766
40,963
39,951
-0.5%
Fixed assets
2,366
2,356
2,487
+0.4%
Goodwill
8,357
8,378
8,316
-0.3%
Intangible assets
2,918
3,430
3,913
-14.9%
Cash and equivalents
2,771
2,531
1,763
+9.5%
Receivables
8,264
8,448
7,800
-2.2%
Inventory
13,198
12,822
12,308
+2.9%
Other assets
2,892
2,998
3,364
-3.5%
Total assets
40,766
40,963
39,951
-0.5%
10-K for the year ended 30 June 2020, filed 13 August 2020: the filing.